LTGO · Latigo Biotherapeutics, Inc. · Fails to Deliver
$15.26
+0.24 (+1.60%)
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 3, 2026
The latest filing states the doubt was alleviated.
“Accordingly, the prior substantial doubt about the Company's ability to continue as a going concern has been alleviated.”View the 10-Q filed Sep 3, 2026
Market Cap
$954.38M
Shares
66.30M
Volume · Oct 26
165.33K
Avg daily vol (56 sessions)
349.92K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-23 | 9,023 | $20.82 | $187,859 |
| 2026-09-22 | 5,656 | $21.11 | $119,398 |
| 2026-09-21 | 15,626 | $22.55 | $352,366 |
| 2026-09-18 | 13,287 | $23.93 | $317,958 |
| 2026-09-17 | 2,706 | $23.06 | $62,400 |
| 2026-09-14 | 72 | $22.15 | $1,595 |
| 2026-09-09 | 1,773 | $23.73 | $42,073 |
| 2026-08-21 | 200 | $21.40 | $4,280 |
| 2026-08-17 | 1,196 | $19.49 | $23,310 |
| 2026-08-12 | 265,284 | $18.52 | $4,913,060 |
| 2026-08-11 | 178,945 | $18.56 | $3,321,219 |
| 2026-08-10 | 168,573 | $18.25 | $3,076,457 |
Showing 1–12 of 12 settlements